Zobrazeno 1 - 2
of 2
pro vyhledávání: '"MESH: Virus Internalization/drug effects"'
Autor:
Sandrine Belouzard, Jens Bukh, Lucie Fénéant, Priscille Brodin, Yves Rouillé, Jean Dubuisson, Laura Riva, Thomas F. Baumert, Alexandre Vandeputte, François Helle, Jannick Prentoe, Laurent L'homme, Laurence Cocquerel, Charles-Henry Gattolliat, Ok-Ryul Song, Tarik Asselah
Publikováno v:
Journal of Virology
Journal of Virology, 2018, 92 (10), pp.e01982-17. ⟨10.1128/JVI.01982-17⟩
Journal of Virology, American Society for Microbiology, 2018, 92 (10), pp.e01982-17. ⟨10.1128/JVI.01982-17⟩
Journal of Virology, 2018, 92 (10), pp.e01982-17. ⟨10.1128/JVI.01982-17⟩
Journal of Virology, American Society for Microbiology, 2018, 92 (10), pp.e01982-17. ⟨10.1128/JVI.01982-17⟩
Hepatitis C virus (HCV) infection causes 500,000 deaths annually, in association with end-stage liver diseases. Investigations of the HCV life cycle have widened the knowledge of virology, and here we discovered that two piperazinylbenzenesulfonamide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eede9d22a44a24224a0d9eb270333e63
https://pubmed.ncbi.nlm.nih.gov/29491159
https://pubmed.ncbi.nlm.nih.gov/29491159
Autor:
Sandrine Belouzard, Dimitri Lavillette, Didier Hober, Laurence Cocquerel, Yves Rouillé, Florian Douam, Noémie Calland, Thibaut Vausselin, Famara Sane, C. Wychowski, Thomas F. Baumert, Julie Potel, Jean Dubuisson, Véronique Descamps, Lucie Fénéant, Gilles Duverlie, Catherine François
Publikováno v:
Journal of Virology
Journal of Virology, American Society for Microbiology, 2015, 89 (16), pp.8346-64. ⟨10.1128/JVI.00192-15⟩
Journal of Virology, 2015, 89 (16), pp.8346-64. ⟨10.1128/JVI.00192-15⟩
Journal of Virology, American Society for Microbiology, 2015, 89 (16), pp.8346-64. ⟨10.1128/JVI.00192-15⟩
Journal of Virology, 2015, 89 (16), pp.8346-64. ⟨10.1128/JVI.00192-15⟩
In our study, we characterized the effect of monensin, an ionophore that is known to raise the intracellular pH, on the hepatitis C virus (HCV) life cycle. We showed that monensin inhibits HCV entry in a pangenotypic and dose-dependent manner. Monens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4909adac1a55bae9e7e9ce2e1823a70
https://hal-univ-lyon1.archives-ouvertes.fr/hal-02487305
https://hal-univ-lyon1.archives-ouvertes.fr/hal-02487305
